Michael Thomas Henderson, Director: Spyre Therapeutics SYRE Sell · Filed 05/08

Trade details

Type: Insider sale
Amount: $2,470,578.36
Shares · price: 33,513 sh · $73.72 a share
Held after: 132,689 sh
Stock: Spyre Therapeutics SYRE
Person: Michael Thomas HendersonDirector
Trade date: 26/05/08
Filed: 26/05/08
Days to filing: 0 days

Sold 20.2% of holdings

Share of holding sold: 20.2%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 04/08~06/07

Michael Thomas Henderson's recent trades

Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
Michael Thomas HendersonDirector
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
Michael Thomas HendersonDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10

Michael Thomas Henderson, Director — sold $2.5M of Spyre Therapeutics SYRE · 20.2% of holdings · 10b5-1 plan | Whalegun